Modal DNA-Values in Prostate Cancer Patients with Deferred Therapy or Endocrine Therapy

Abstract

Modal DNA-values were assessed with Pow cytometry ir. 269 patients with newly detected untreated prostate cancer. One hundred and seventy-two patients with low-grade, low-stage, non-metastasized cancers were followed without treatment and in this group initial tumor ploidy had no prognostic value. Ninety-seven patients with clinically more advanced prostat: cancers were subjected to endocrine therapy and in this group ploidy was prognostic regarding cancer-related sunival.

Key Words:

• Prostate cancer
• modal DNA-value
• deferred therapy
• endocrine therapy
• survival